title: Magnetization transfer imaging in AIDS-related brain diseases.
abstract: MT makes it possible to characterize tissue destruction in several CNS diseases, including AIDS-related diseases such as PML or HIV encephalitis. MR may be helpful in establishing diagnosis, disease burden, prognosis, and therapeutic efficacy. MT may also contribute to the investigation of the natural history of the diseases. The other application is in improving contrast after the injection of gadolinium chelates. This contrast improvement can be achieved routinely on any device and may be a good alternative to other methods, such as increasing dose or delay.
authors.affiliation: Service de Neuroradiologie, Hôpital Pellegrin, Bordeaux, France.
authors.forename: V
authors.initials: V
authors.lastname: Dousset
authors.forename: J P
authors.initials: JP
authors.lastname: Armand
authors.forename: P
authors.initials: P
authors.lastname: Huot
authors.forename: B
authors.initials: B
authors.lastname: Viaud
authors.forename: J M
authors.initials: JM
authors.lastname: Caille
mesh_terms: D015526:AIDS Dementia Complex / Q000175:diagnosis* / Q000628:therapy; D001927:Brain Diseases / Q000175:diagnosis / Q000628:therapy / Q000821:virology; D003287:Contrast Media; D018450:Disease Progression; D018792:Encephalitis, Viral / Q000175:diagnosis / Q000628:therapy; D005682:Gadolinium; D015658:HIV Infections / Q000175:diagnosis / Q000628:therapy; D006801:Humans; D007089:Image Enhancement; D007968:Leukoencephalopathy, Progressive Multifocal / Q000175:diagnosis / Q000628:therapy / Q000821:virology; D008279:Magnetic Resonance Imaging; D011379:Prognosis
chemical_list: D003287:Contrast Media; D005682:Gadolinium